Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients

Clinical trial NCT00133224 · TERMINATED

Trial details

NCT number: NCT00133224
Sponsor: Cell Genesys
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2005-07-01
Primary completion: 2008-08-01
Enrollment: 408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.